Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Lack of trading activity at the open

<< Previous

Bullboard Posts

Next >>

Post by SPCEO1on May 09, 2022 9:41am

193 Views

Post# 34666435

Lack of trading activity at the open

Does anyone have any reasonable explanation for this clear trend of nothing happening in early trading for THTX. And I mean nothing at all - very strange. There is almost always activity later in the day but it seems like those who are paying attention to THTX are all late sleepers!

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec